🔎 Trials Near Me

ホーム › 2型糖尿病 › バージニア

バージニアにおける2型糖尿病の臨床試験

バージニア内の拠点で、2型糖尿病に関する26件の研究が参加者を募集しています。

バージニア内の都市

公式研究テキスト(英語)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Tidewater Physicians Multispecialty Group, Newport News
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Seven Corners Medical Center, Falls Church
  • Carient Heart and Vascular, Manassas
  • York Clinical Research, Norfolk
  • 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Carient Heart & Vascular - Manassas, Manassas
  • Carient Heart and Vascular LLC-Reston, Reston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Tidewater Physicians Multispecialty Group, Newport News
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07817251

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Chippenham Johnston Willis Medical Center, Richmond
被験者募集中健康なボランティア歓迎
55歳以上 · 全性別 · 2026/09/28更新 · NCT06112418

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • York Clinical Research, LLC, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Manassas
  • Research Site, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

Cooking Health-Oriented Meals to Prevent Dementia and Diabetes

  • Virginia Tech, Blacksburg
被験者募集中健康なボランティア歓迎
50歳〜75歳 · 全性別 · 2026/09/16更新 · NCT07661368

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Hampton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Conquest Research - Arlington, Vienna
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/15更新 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Manassas Clinical Research Center, Manassas
  • Centricity Research Suffolk Primary Care, Suffolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Leesburg
  • Research Site, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • UVA Health Systems, Charlottesville
被験者募集中第3相
10歳〜18歳 · 全性別 · 2026/09/09更新 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Suffolk, Suffolk
  • Conquest Research, Vienna
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
  • Clinical Research Partners, LLC, Richmond
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Manassas Clinical Research Center Inc, Manassas
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Carient Heart and Vascular, Manassas
  • Dominion Medical Associates, Richmond
  • VA Medical Center_Salem, Salem
  • 他1件
被験者募集中第3相
45歳以上 · 全性別 · 2026/09/01更新 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Arlington
  • Research Site, Newport News
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662109

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Manassas Clinical Research Center, Manassas
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT07527650

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Riverside Family Medicine Residency Program, Newport News
被験者募集中
18歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07521475

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • Burke Internal Medicine and Research, Burke
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/06/15更新 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • Burke Internal Medicine & Research, Burke
  • Tekton Research, Midlothian
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/23更新 · NCT07546929

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

  • University of Virginia Center for Diabetes Technology, Charlottesville
被験者募集中
30歳〜80歳 · 全性別 · 2026/04/09更新 · NCT05766735

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

  • University of Virginia, Charlottesville
被験者募集中健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/03/23更新 · NCT04791371

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Foot and Ankle Specialists of the Mid-Atlantic, Salem
被験者募集中
18歳以上 · 全性別 · 2025/02/10更新 · NCT06681428

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。